Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: Analysis of pooled data from two clinical trials

Sean P. David, David R. Strong, Marcus R. Munafò, Richard A. Brown, Elizabeth E. Lloyd-Richardson, Paul E. Wileyto, Eden A. Evins, Peter G. Shields, Caryn Lerman, Raymond Niaura

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: Analysis of pooled data from two clinical trials'. Together they form a unique fingerprint.

Neuroscience

Keyphrases

Immunology and Microbiology